LYRA · Lyra Therapeutics, Inc.
$0.50
+0.00 (+0.00%)
At close · Jul 28
Going-concern doubt
— flagged Mar 31, 2026
Substantial doubt about the company's ability to continue as a going concern.
“our recurring losses from operations raise substantial doubt regarding our ability to continue as a going concern”View the 10-K filed Mar 31, 2026
Market Cap
$887,441
Shares
1.77M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2025-06-02 | Lyra Therapeutics ENLIGHTEN 2 Phase 3 Results | Event |
Source: https://investors.lyratherapeutics.com/corporate-governance/governance-overview